Trials / Completed
CompletedNCT03481257
Comparison Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel
Comparison of Shear Stress-induced Thrombotic and Thrombolytic Effect d Thrombolytic Effect Between Ticagrelor Versus Very Low Dose Rivaroxaban With Clopidogrel in Patients With Acute Coronary Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 56 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A total of 50 participants diagnosed with ACS (group A ticagrelor 180mg/d, n=25), group B (clopidogrel 75mg + rivaroxaban 5mg/ d, n=25)) were consecutively enrolled and treated with study drugs on top of aspirin (100mg/d) for 1 month. VerifyNow® and Global thrombosis test were performed at day 2 and 1 month after administration of study drugs. The investigators compared aspirin reaction unit (ARU) and P2Y12 reaction unit (PRU), occlusion time (OT) which reflects shear stress-induced thrombotic activity, and lysis time (LT) which showed endogenous lytic activity between the two strategies at both time points.
Conditions
Timeline
- Start date
- 2017-04-12
- Primary completion
- 2018-01-04
- Completion
- 2018-02-04
- First posted
- 2018-03-29
- Last updated
- 2018-03-29
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03481257. Inclusion in this directory is not an endorsement.